Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The target "POM121 membrane glycoprotein pseudogene" (Ensembl: ENSG00000257129) refers to a **pseudogene** related to the POM121 family of nuclear pore membrane glycoproteins[4]. *Pseudogenes* are non-functional copies of genes that usually do not encode active proteins and typically lack biological function. They do not produce functional protein products and are not considered drug targets. The canonical POM121 proteins, in contrast, are core components of the nuclear pore complex with key roles in nucleocytoplasmic transport, cancer, and metabolic diseases; however, pseudogenes do not share these functional or therapeutic properties[1][5]. **Summary:** This entry refers to a pseudogene, not an actual protein-coding gene or therapeutic target. As such, it is not suitable for structured target information as required for active drug targets, receptors, enzymes, or other actionable biomolecules.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on POM121 membrane glycoprotein pseudogene.